ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Understanding cancer survivor cost communication experiences and preferences.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prognostic communication preferences of cancer patients: A hybrid concept analysis.International journal of nursing sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeAlthough cost discussions between cancer patients and their oncology providers are associated with lower out-of-pocket costs, patient experiences and preferences surrounding these conversations are relatively unexplored.
methodsThis qualitative study, conducted March-April 2022, assessed patient-provider cost communication in a convenience sample of cancer survivors aged 26-60 and less than 5 years from diagnosis. Semi-structured interviews were recorded, transcribed, and coded using iterative content analysis to identify emerging patterns and themes.
resultsSurvivors (N = 20) were 65% female and 75% non-Hispanic White with a median diagnosis age of 47.5 years. Main themes included survivor cost conversation experiences and preferences, with subthemes such as cost information seeking, advantages and disadvantages of cost discussions, and optimal timing for financial discussions. Most patients (65%) preferred to discuss costs before initiating cancer treatment but after a cancer diagnosis. One patient shared, "Not at diagnosis. That is the most devastating time of your life…" Most survivors (90%) wanted family involved in cost conversations for ease of understanding and recollection. When asked whether their oncologist should consider out-of-pocket costs during treatment planning, 60% of survivors preferred their oncologist to consider costs to aid patients in financial planning, avoiding unexpected expenses, and decreasing stress/anxiety.
conclusionPatient preferences regarding cancer treatment cost-related communications are highly individualized. Information on how to assess patient cost communication preferences during cancer care delivery is needed to address cost-related challenges facing cancer survivors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.